Literature DB >> 24389577

A common angiotensin-converting enzyme polymorphism and preoperative angiotensin-converting enzyme inhibition modify risk of tachyarrhythmias after congenital heart surgery.

Andrew H Smith1, English C Flack2, Kristie Y Borgman2, Jill P Owen3, Frank A Fish2, David P Bichell4, Prince J Kannankeril2.   

Abstract

BACKGROUND: The angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism is described in association with numerous phenotypes, including arrhythmias, and may provide predictive value among pediatric patients undergoing congenital heart surgery.
OBJECTIVE: The purpose of this study was to examine the role of a common polymorphism on postoperative tachyarrhythmias in a large cohort of pediatric patients undergoing congenital heart surgery with cardiopulmonary bypass (CPB).
METHODS: Subjects undergoing congenital heart surgery with CPB at our institution were consecutively enrolled from September 2007 to December 2012. In addition to DNA, perioperative clinical data were obtained from subjects.
RESULTS: Postoperative tachyarrhythmias were documented in 45% of 886 enrollees and were associated with prolonged mechanical ventilation (P <.001) and intensive care unit length of stay (P <.001). ACE I/D was in Hardy-Weinberg equilibrium (19% I/I, 49% I/D, 32% D/D). I/D or D/D genotypes were independently associated with a 60% increase in odds of new tachyarrhythmia (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.1-2.3, P = .02). Preoperative ACE inhibitor administration was independently associated with a 47% reduction in odds of postoperative tachyarrhythmia in the entire cohort (OR 0.53, 95% CI 0.32-0.88, P = .01), driven by a 5-fold reduction in tachyarrhythmias among I/I genotype patients (OR 0.19, 95% CI 0.04-0.88, P = .02).
CONCLUSION: The risk of tachyarrhythmias after congenital heart surgery is independently affected by the ACE I/D polymorphism. Preoperative ACE inhibition is associated with a lower risk of postoperative tachyarrhythmias, an antiarrhythmic effect that appears genotype dependent. An understanding of genotype variation may play an important role in the perioperative management of congenital heart surgery.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmias; Cardiac surgery; Congenital heart disease; Genomics; Pharmacogenetics

Mesh:

Substances:

Year:  2014        PMID: 24389577      PMCID: PMC4003870          DOI: 10.1016/j.hrthm.2014.01.005

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  39 in total

1.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

2.  Early postoperative arrhythmias after pediatric cardiac surgery.

Authors:  Jeffrey W Delaney; Jose M Moltedo; James D Dziura; Gary S Kopf; Christopher S Snyder
Journal:  J Thorac Cardiovasc Surg       Date:  2006-06       Impact factor: 5.209

3.  Magnesium supplementation in the prevention of arrhythmias in pediatric patients undergoing surgery for congenital heart defects.

Authors:  B H Dorman; R M Sade; J S Burnette; H B Wiles; M L Pinosky; S T Reeves; B R Bond; F G Spinale
Journal:  Am Heart J       Date:  2000-03       Impact factor: 4.749

4.  Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.

Authors:  Mehmet Ozaydin; Ercan Varol; Yasin Türker; Oktay Peker; Doğan Erdoğan; Abdullah Doğan; Erdoğan Ibrişim
Journal:  Anadolu Kardiyol Derg       Date:  2010-04

5.  Risk factors for cardiac arrhythmias in children with congenital heart disease after surgical intervention in the early postoperative period.

Authors:  Joanna Rekawek; Andrzej Kansy; Maria Miszczak-Knecht; Małgorzata Manowska; Katarzyna Bieganowska; Monika Brzezinska-Paszke; Elzbieta Szymaniak; Anna Turska-Kmieć; Przemysław Maruszewski; Piotr Burczyński; Wanda Kawalec
Journal:  J Thorac Cardiovasc Surg       Date:  2007-04       Impact factor: 5.209

6.  Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.

Authors:  C Michael White; Jeffrey Kluger; Kirkeith Lertsburapa; Osman Faheem; Craig I Coleman
Journal:  Eur J Cardiothorac Surg       Date:  2007-03-12       Impact factor: 4.191

7.  Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment.

Authors:  Timothy M Hoffman; David M Bush; Gil Wernovsky; Mitchell I Cohen; Tammy S Wieand; J William Gaynor; Thomas L Spray; Larry A Rhodes
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

8.  Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants.

Authors:  David A Hehir; Troy E Dominguez; Jean A Ballweg; Chitra Ravishankar; Bradley S Marino; Geoffrey L Bird; Susan C Nicolson; Thomas L Spray; J William Gaynor; Sarah Tabbutt
Journal:  J Thorac Cardiovasc Surg       Date:  2008-05-22       Impact factor: 5.209

9.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

Authors:  A H Danser; M A Schalekamp; W A Bax; A M van den Brink; P R Saxena; G A Riegger; H Schunkert
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

10.  Postoperative junctional ectopic tachycardia: risk factors for occurrence in the modern surgical era.

Authors:  Jeffrey P Moak; Patricio Arias; Jonathan R Kaltman; Yao Cheng; Robert McCarter; Sridhar Hanumanthaiah; Gerard R Martin; Richard A Jonas
Journal:  Pacing Clin Electrophysiol       Date:  2013-05-10       Impact factor: 1.976

View more
  5 in total

1.  Genotypic and phenotypic predictors of complete heart block and recovery of conduction after surgical repair of congenital heart disease.

Authors:  Laura E Murray; Andrew H Smith; English C Flack; Kim Crum; Jill Owen; Prince J Kannankeril
Journal:  Heart Rhythm       Date:  2016-11-05       Impact factor: 6.343

2.  Analysis of clinical and candidate genetic risk factors for postoperative atrial tachycardia after congenital heart surgery in infants.

Authors:  Amy M O'Connor; Andrew H Smith; Kim Crum; Todd L Edwards; Prince J Kannankeril
Journal:  Am Heart J       Date:  2018-04-30       Impact factor: 4.749

Review 3.  Heart Failure in Pediatric Patients With Congenital Heart Disease.

Authors:  Robert B Hinton; Stephanie M Ware
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

4.  Incidence and effect of early postoperative ventricular arrhythmias after congenital heart surgery.

Authors:  Sarah R Fuchs; Andrew H Smith; Sara L Van Driest; Kim F Crum; Todd L Edwards; Prince J Kannankeril
Journal:  Heart Rhythm       Date:  2018-12-05       Impact factor: 6.343

5.  Metabolic Response to Stress by the Immature Right Ventricle Exposed to Chronic Pressure Overload.

Authors:  Masaki Kajimoto; Muhammad Nuri; Nancy G Isern; Isabelle Robillard-Frayne; Christine Des Rosiers; Michael A Portman
Journal:  J Am Heart Assoc       Date:  2019-08-27       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.